In an era of transforming technologies in molecular sequencing, imaging, and artificial intelligence, there is an urgent need for skilled researchers who can bridge the gap between biomedical and computational sciences. Professor Eduardo Eyras is helping address that gap.
-
-
Advancing cell biology and equity in science
News / 1 May 2025
Dr Vaishnavi Ananthanarayanan is an innovative cell biologist whose research explores the intricate mechanisms of cellular organisation and a passionate advocate for equity, diversity and inclusion (EDI) in science.
-
Guiding cancer-fighting cells to solid tumours
News / 1 May 2025
A/Prof Maté Biro (UNSW Sydney) combines his expertise in cellular biology and advanced microscopy to improve cancer treatment efficacy, paving the way for next-generation therapies that could revolutionise the fight against cancer.
-
Building biotech to transform regenerative medicine
News / 1 May 2025
A/Prof Mikaël Martino (Monash University) is a renowned innovator in regenerative medicine, known for translating ground-breaking technologies into impactful solutions with the potential to reshape tissue repair and improve patient outcomes.
-
Transforming local genomics research with world-class infrastructure
News / 1 May 2025
The long-term support and stability provided to EMBL Australia group leaders enables them to drive transformative advances in Australian research infrastructure, just as Professor David Lynn did.
-
Building lab-grown muscles to study ageing and disease
News / 1 May 2025
Dr William Roman is one of the EMBL Australia group leaders pioneering groundbreaking technologies to tackle longstanding scientific challenges.
-
Developing advanced imaging tools to benefit the scientific community
News / 1 May 2025
Dr Senthil Arumugam, an EMBL Australia group leader at the Monash Biomedicine Discovery Institute, is advancing Australia’s scientific infrastructure by developing world-class imaging tools – including a lattice light-sheet microscope with adaptive optics – to deliver exciting new findings.
-
Identifying gaps & driving solutions in RNA research infrastructure
News / 1 May 2025
His nine-year tenure as an EMBL Australia group leader allowed Professor Chen Davidovich to make and nurture connections with other ambitious researchers across Australia, enabling him to identify a critical gap in the nation’s research infrastructure and address it by establishing a dedicated RNA mass spectrometry platform.
-
Decoding epigenetics to unlock new cancer therapies
News / 1 May 2025
Dr Qi Zhang is one of the EMBL Australia group leaders conducting ambitious, foundational research that paves the way for addressing some of the greatest health challenges in modern medicine.
-
Scientific excellence without borders
News / 1 May 2025
Associate Professor Robert Weatheritt exemplifies how Australia’s EMBL membership attracts top-tier global talent, fosters valuable international collaborations and positions Australia at the forefront of life sciences research.